undefined

Robert Ang

CEO of Cambridge, Mass.-based Vor Bio, using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app